Randomized Controlled Trial of a Drug Regimen That Includes Ciprofloxacin for the Treatment of Pulmonary Tuberculosis

The fluoroquinolones are promising new antituberculous agents. A randomized controlled trial of 200 adult patients with sputum smear-positive pulmonary tuberculosis was conducted in Tanzania. Patients received either a trial regimen (HRC) consisting of isoniazid (300 mg), rifampin (600 mg), and cipr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 1996-05, Vol.22 (5), p.827-833
Hauptverfasser:	N. Kennedy, Berger, L., Curram, J., Fox, R., Gutmann, J., G. M. Kisyombe, F. I. Ngowi, A. R. C. Ramsay, A. O. S. Saruni, N. Sam, Tillotson, G., L. O. Uiso, Yates, M., Gillespie, S. H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult AIDS-Related Opportunistic Infections - drug therapy AIDS/HIV Anti-Infective Agents - administration & dosage Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Antitubercular Agents - administration & dosage Antituberculars Biological and medical sciences Ciprofloxacin - administration & dosage Clinical Articles Cultural groups Ethambutol - administration & dosage Female Fluoroquinolones HIV-1 Humans Isoniazid - administration & dosage Male Medical sciences Middle Aged Mycobacterium tuberculosis Pharmacology. Drug treatments Pulmonary tuberculosis Pyrazinamide - administration & dosage Radiology Relapse Rifampin - administration & dosage Sputum Sterilization Time Factors Tuberculosis Tuberculosis, Pulmonary - complications Tuberculosis, Pulmonary - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!